Vivus (VVUS - Get Report) is engaged in development and commercialization of therapeutic drugs for large underserved markets, including obesity and related morbidities, such as sleep apnea and diabetes and men's sexual health. This stock is trading up 4.1% at $12.55 in recent trading.
Today's Volume: 3.3 millionAverage Volume: 1.6 million Volume % Change: 176% From a technical standpoint, VVUS is flirting with a number of a big breakout trades if this stock can manage to take out some past overhead resistance at $12.98 and then $13.68 with volume. At last check, VVUS hit $12.84 intraday and volume is well above the average action. Traders should be cautious on VVUS if it fails to take out those breakout levels soon, since the volume is so strong today and it's still trading below them. Vivus is rated D sell by TheStreet Ratings.